Hope Medicine Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Series B2

  • Latest Deal Amount
  • $18.5M

  • Investors
  • 8

Hope Medicine General Information

Description

Developer of clinical-stage biopharmaceuticals designed to treat endocrine, cardiovascular, and metabolic diseases. The company utilizes disease biology and translational medicine to develop monoclonal antibodies and small molecule drugs for endocrine, cardiovascular and metabolic diseases, enabling patients to access affordable treatments for unmet medical needs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Block Y1
  • Number 112 Liangxiu Road, Pudong
  • Shanghai
  • China
+86 021
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Block Y1
  • Number 112 Liangxiu Road, Pudong
  • Shanghai
  • China
+86 021

Hope Medicine Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hope Medicine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B2) 27-Sep-2024 $18.5M Completed Generating Revenue
3. Early Stage VC (Series B1) 30-Nov-2023 Completed Generating Revenue
2. Early Stage VC (Series B) 06-May-2021 $56M $56M Completed Generating Revenue
1. Early Stage VC (Series A) 31-Mar-2019 Completed Generating Revenue
To view Hope Medicine’s complete valuation and funding history, request access »

Hope Medicine Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hope Medicine Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
VMS Group (Hong Kong) Growth/Expansion Minority
Wuxi Capital Group Venture Capital Minority
Grand Flight Corporate Venture Capital Minority
Highlight Capital Venture Capital Minority
Qiming Venture Partners Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Hope Medicine FAQs

  • When was Hope Medicine founded?

    Hope Medicine was founded in 2018.

  • Where is Hope Medicine headquartered?

    Hope Medicine is headquartered in Shanghai, China.

  • What is the size of Hope Medicine?

    Hope Medicine has 5 total employees.

  • What industry is Hope Medicine in?

    Hope Medicine’s primary industry is Drug Discovery.

  • Is Hope Medicine a private or public company?

    Hope Medicine is a Private company.

  • What is Hope Medicine’s current revenue?

    The current revenue for Hope Medicine is .

  • How much funding has Hope Medicine raised over time?

    Hope Medicine has raised $102M.

  • Who are Hope Medicine’s investors?

    VMS Group (Hong Kong), Wuxi Capital Group, Grand Flight, Highlight Capital, and Qiming Venture Partners are 5 of 8 investors who have invested in Hope Medicine.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process